Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 17, 2014

Drug Name Review Type Class Manufacturer
Otezla New Drug Initial Review Phosphodiesterase 4 Inhibitor Celgene
Hemangeol New Drug Initial Review Beta-Adrenergic Blocker Pierre Fabre
Opsumit New Drug Initial Review Pulmonary Aterial Hypertension Actelion
Orenitram ER New Drug Initial Review Pulmonary Aterial Hypertension United Therapeutics
Mycamine New Drug Initial Review Anti-fungal Astellas
Ambisome New Drug Initial Review Anti-fungal Astellas
Brilinta PDL Appeal Platelet Aggregation Inhibitor Astra Zeneca